Clin2
NCT07107971Possibly a fitRecruiting

Drug balloon vs. standard care for fatty heart plaques

Coronary Artery DiseaseAtherosclerosesCardiovascular DiseaseVulnerable Coronary PlaquesVulnerable PlaqueLipid-Rich Atherosclerosis of Coronary ArteryAcute Coronary Syndromes (ACS)

Part of Heart & circulation clinical trials.

This study compares a drug-coated balloon (which releases medicine into the artery) with standard medicines alone for treating fatty plaques in the heart arteries. It is for people who have already had a heart attack and a successful opening of a blocked artery.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
400 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You've recently had a heart attack or unstable angina (acute coronary syndrome).
  • You had a successful angioplasty (balloon or stent) to open a blocked artery.
  • At least two of your heart arteries are not completely blocked and are between 2 and 6 mm wide.
  • You are not on life support or medicines for shock (hemodynamically stable).
  • You do not have an allergy to paclitaxel (the drug on the balloon).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07817719Not yet recruiting
Drug-coated balloon alone after reopening a blocked heart artery

This study tests whether using only a drug-coated balloon (a tiny balloon that releases medicine to keep the artery open) after reopening a fully blocked heart artery can work well without placing a permanent stent. If you've had a blocked artery for a while and it was recently reopened, this approach might help keep it open with fewer long-term implants.

São Paulo, São Paulo
NCT06928883Not yet recruiting
Drug-coated balloon for non-blocking heart plaque after a heart attack

This study is testing a special balloon that releases a drug (sirolimus) to treat fatty plaques in heart arteries that are not yet blocking blood flow. The hope is that this treatment can stabilize or even shrink these plaques, reducing future risk of heart attacks. If you have recently had a heart attack and have other non-obstructive plaques, this trial might offer a new approach.

Lugano
NCT06275386Recruiting
Drug-coated balloon for chronic heart artery blockages

This trial tests whether a special balloon coated with medicine (drug-coated balloon) can safely open a completely blocked heart artery, instead of using a permanent stent. It may be an option for people who have chronic chest pain or shortness of breath due to a long-standing blockage.

Warsaw, Masovian Voivodeship
NCT07397845Recruiting
Stents vs drug-coated balloons for small or complex heart vessels

This trial compares two treatments—stents and paclitaxel-coated balloons—for people with narrowed heart arteries that are small, long, or complex. It aims to find which option works better to restore blood flow.

Lucerne, Canton of Lucerne
NCT07514988Not yet recruiting
Drug-coated balloons for recent heart artery blockages

This study compares two kinds of drug-coated balloons used during angioplasty to open narrowed heart arteries in people with acute coronary syndrome. Both balloons slowly release medicine to help keep the artery open, and the trial aims to see if one works better than the other.

Beijing, Beijing Municipality
NCT02038660Recruiting
Drug-coated balloon treatment registry for narrowed blood vessels

This study records outcomes for people who get a drug-coated balloon used to treat a narrowed blood vessel after a first balloon treatment. It may help doctors understand how well this approach works in everyday care and for different patient needs.

Bucheon-si

Hear when a new Coronary artery disease trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.